tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
COSMO Pharmaceuticals N.V. (CH:COPN)
:COPN
Switzerland Market
COPN
COSMO Pharmaceuticals N.V.
RESEARCH TOOLSreports

COSMO Pharmaceuticals N.V. (COPN) Stock News & Sentiment

Compare
18 Followers
Cosmo Pharmaceuticals Enters Scale-Up Phase on Strong 2025 Results and AI, Dermatology Pipeline Momentum
Premium
Company Announcements
Cosmo Pharmaceuticals Enters Scale-Up Phase on Strong 2025 Results and AI, Dermatology Pipeline Momentum
2d ago
Cosmo Pharmaceuticals’ Breezula: A Promising Breakthrough in Hair-Loss Treatment with Significant Market Potential
Premium
Ratings
Cosmo Pharmaceuticals’ Breezula: A Promising Breakthrough in Hair-Loss Treatment with Significant Market Potential
1M ago
Cosmo Pharmaceuticals Unveils Breakthrough Results for Male Hair Loss Treatment
Premium
Company Announcements
Cosmo Pharmaceuticals Unveils Breakthrough Results for Male Hair Loss Treatment
1M ago
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in Brazil
Premium
Company Announcements
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in Brazil
2M ago
Cosmo Pharmaceuticals Advances in Sustainability with Enhanced ESG Rating and EcoVadis Recognition
Premium
Company Announcements
Cosmo Pharmaceuticals Advances in Sustainability with Enhanced ESG Rating and EcoVadis Recognition
2M ago
Cosmo Pharmaceuticals to Engage Investors at Key Conferences
Premium
Company Announcements
Cosmo Pharmaceuticals to Engage Investors at Key Conferences
2M ago
Cosmo Pharmaceuticals Secures CE Certification for ColonPRO EU, Expanding AI Colonoscopy Platform to Europe
Premium
Company Announcements
Cosmo Pharmaceuticals Secures CE Certification for ColonPRO EU, Expanding AI Colonoscopy Platform to Europe
2M ago
More CH:COPN News >

COPN News on the Web

Cosmo Pharmaceuticals Posts EUR 104 Mln Revenue, Midpoint Of 2025 Guidance Range
rttnews
Neutral
COSMO Pharmaceuticals N.V. (0RGI) Receives a Buy from Kepler Capital
TipRanks News
Neutral
COSMO Pharmaceuticals N.V. (0RGI) Gets a Buy from Kepler Capital
TipRanks News
Neutral
COSMO Pharmaceuticals N.V. (0RGI) Receives a Buy from Kepler Capital
TipRanks News
Neutral
Cosmo Pharmaceuticals Advances AI and GI Drug Development at DDW 2025
TipRanks News
Neutral
Kepler Capital Sticks to Their Buy Rating for COSMO Pharmaceuticals N.V. (0RGI)
TipRanks News
Neutral
COSMO Pharmaceuticals N.V. (0RGI) Gets a Buy from Kepler Capital
TipRanks News
Neutral
COSMO Pharmaceuticals N.V. (0RGI) Receives a Buy from Kepler Capital
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CH:COPN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:COPN’s Media Buzz Sentiment?
1 articles about CH:COPN were published this week. In an average week, 1 articles are published.
    What is CH:COPN’s weekly average amount of articles?
    In an average week, 1 articles about CH:COPN are published.
      What is CH:COPN’s News Sentiment?
      50% of articles about CH:COPN were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        KRYSKrystal Biotech
        RVMDRevolution Medicines
        RPRXRoyalty Pharma
        NYXHNyxoah
        BCTBriaCell Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week